✦ LIBER ✦

Novel Therapeutics in Acute Myeloid Leukemia

✍ Scribed by Sweet, Kendra; Lancet, Jeffrey E.

Book ID: 125375975
Publisher: Current Science Inc.
Year: 2014
Tongue: English
Weight: 228 KB
Volume: 9
Category: Article
ISSN: 1558-8211
DOI: 10.1007/s11899-014-0199-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel therapeutic agents in acute myeloi

Novel therapeutic agents in acute myeloid leukemia

✍ Richard M. Stone 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Targeting AML1/ETO-Histone Deacetylase R

Targeting AML1/ETO-Histone Deacetylase Repressor Complex: A Novel Mechanism for Valproic Acid-Mediated Gene Expression and Cellular Differentiation in AML1/ETO-Positive Acute Myeloid Leukemia Cells

✍ Liu, S.; Klisovic, R. B.; Vukosavljevic, T.; Yu, J.; Paschka, P.; Huynh, L.; Pan 📂 Article 📅 2007 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 417 KB

Therapeutic Advances in Acute Myeloid Le

Therapeutic Advances in Acute Myeloid Leukemia

✍ Burnett, A.; Wetzler, M.; Lowenberg, B. 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 192 KB

Novel agents in acute myeloid leukemia

✍ Ungewickell, Alexander; Medeiros, Bruno C. 📂 Article 📅 2012 🏛 Carden Jennings Publishing 🌐 English ⚖ 415 KB

Acute myeloid leukemia: Therapeutic impa

Acute myeloid leukemia: Therapeutic impact of epigenetic drugs

✍ Lucia Altucci; Nicole Clarke; Angela Nebbioso; Annamaria Scognamiglio; Hinrich G 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Acute myeloid leukemia in the elderly: b

Acute myeloid leukemia in the elderly: biology and therapeutic strategies

✍ A Pinto; V Zagonel; F Ferrara 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Age represents one of the most important adverse prognostic factors in acute myeloid leukemia (AML). The therapeutic results for patients older than 60 years accrued into clinical trials of intensive chemotherapy are largely unsatisfactory (complete remission rates rarely superior to 50-60%; median